Latest news with #KMDA
Time of India
3 days ago
- Business
- Time of India
Metro seeks 20cr from KMDA for Chingrighata subway
Kolkata: Metro has asked KMDA to deposit 50% — Rs 20 crore — of the cost of the proposed underpass at Chingrighata. Rail Vikas Nigam Ltd (RVNL), the implementing agency of the New Garia-Airport corridor, will share half the cost "according to the agreement with the state govt". KMDA has also been asked to approve the construction methodology submitted by RVNL three years ago. TOI reported on May 28 that "RVNL is preparing the detailed project report for the proposed three-way pedestrian underpass at Chingrighata", after cops decided to withhold traffic blocks at the busy crossing for two weekend nights until the underpass was built. The weekend traffic regulation is needed for bridging the last 366m viaduct gap of the Orange line's Ruby-Sector V section. Girder-launching work at the Chingrighata crossing has been stalled since Feb 2. RVNL cannot meet its June 2025 deadline to complete the 8km Phase II. KMC's nod for the underpass' basic design, submitted by RVNL in June 2022, came on April 8, 2025. "Even as the most crucial part of the project remains stalled at Chingrighata, RVNL is going ahead with the underpass construction, as told by the state govt," a railway official said. The urban development department planned the underpass at Chingrighata along with the foot overbridge as a two-pronged approach towards reducing accidents at the busy intersection. At a proposed depth of two-and-a-half metres, the underpass would be three-and-a-half metres wide, with openings on Canal South Road, Sukantanagar, and Jal Vayu Vihar.
Time of India
30-05-2025
- Time of India
KMDA to raze illegal shanties under canal bridges
Kolkata: The Kolkata Metropolitan Development Authority has decided to demolish unauthorised structures under several canal bridges across the city. They will also set up barricades to prevent further encroachment at these spots. Tired of too many ads? go ad free now The canal bridges where the authorities plan to clear encroachments and install barricades include Karunamoyee Bridge, Chetla Lock Gate bridge, Chitpore bridge, Bagmari bridge, Salt Lake slip bridge, and Chetla RCC bridge. Officials said these bridges, which span different canals across the city, have shanties under them on the canal sides. "Last year, a fire broke out in a slum under Durgapur bridge in New Alipore. The bridge was damaged and KMDA had to take up repair work. There are encroachments, like shanties and makeshift structures, under several such bridges that need to be cleared to prevent similar incidents," said a KMDA official. KMDA has started the process to engage agencies for the job at an estimate of nearly Rs 50 lakh. — Suman Chakraborti
Time of India
28-05-2025
- Time of India
Chingrighata, Bypass bridge to get steel barriers for pedestrians' safety
Kolkata: In a bid to prevent risky pedestrian crossovers on the city's highest-speed corridor, the KMDA has started the process of setting up steel barricades on the stretch below Chingrighata and Ambedkar Bridge on EM Bypass following suggestions from the traffic cops. The authorities will engage an agency to execute the work at an estimated cost of about Rs 23.6 lakh. The agency will need to complete the work within a month from the date of commencement of the project. "Over 35% of all pedestrian deaths occur because they stray on the roads. Putting up iron fencing will stop jaywalking and significantly cut down accidents," a traffic police officer said. Traffic police said they had been trying to bring down the number of accidents on stretches below flyovers and bridges. "Footage has shown vehicles straying from one lane to another to overtake one another, especially near faster corridors on Bypass and its connectors," a cop said. Kolkata saw 118 pedestrian victims on the five most dangerous stretches since 2020. Bypass took the top spot, cops said.
Time of India
24-05-2025
- Automotive
- Time of India
Carriageway repairs start on Ultadanga slip bridge
1 2 3 Kolkata: The Kolkata Metropolitan Development Authority (KMDA) has started carriageway repair work of the one-way Ultadanga slip bridge over Kestopur canal, connecting VIP Road with Salt Lake. On Friday, one lane of the slip bridge was left open for vehicles to move as bituminous mastic work was being done, blocking the other lane. Officials said the carriageway, which is a one-way slip bridge, deteriorates quite often as the authorities take up carriageway repair work as and when needed. With the monsoon ahead, the bridge's carriageway stretch which was damaged in several spots, needed to be repaired to prevent further deterioration, officials said. Named as a slip bridge, which is only about 100 metres in length, the bridge is used as a short-cut for vehicles to move towards Salt Lake and EM Bypass from VIP Road. KMDA is also working on the plan to set up another Bailey bridge over Kestopur canal for vehicles to enter VIP Road from Salt Lake, bypassing the traffic congestion at Ultadanga. Bidhannagar MLA and minister Sujit Bose, along with KMDA officials and Bidhannagar traffic police officers, recently conducted an inspection to finalise the proposed site on the canal side at Salt Lake AA Block where the bridge would be set up. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like בלב ת"א: יחידות מגורים יימכרו מ-2.5 מיליון ש"ח Channel22 Undo Officials said once the bridge is set up, it would be the second Bailey bridge and fourth bridge overall over Kestopur canal, after the Bailey bridge at Lake Town, Ultadanga slip bridge and the bituminous carriageway both-way bridge at the junction of AK and AJ blocks. Get the latest lifestyle updates on Times of India, along with Brother's Day wishes , messages and quotes !
Yahoo
15-05-2025
- Business
- Yahoo
Kamada Ltd (KMDA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion
Release Date: May 14, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Kamada Ltd (NASDAQ:KMDA) reported a strong first quarter with total revenues of $44 million, marking a 17% increase year over year. The company achieved a significant 54% year-over-year increase in adjusted EBITDA, reaching $11.6 million. Kamada Ltd (NASDAQ:KMDA) reiterated its 2025 annual guidance, projecting annual revenues between $178 million to $182 million and adjusted EBITDA between $38 million to $42 million. The company is advancing its four-pillar growth strategy, which includes organic commercial growth, business development, M&A transactions, and plasma collection operations. Kamada Ltd (NASDAQ:KMDA) expanded its plasma collection operation with a new center in San Antonio, Texas, expected to contribute significantly to annual revenues. Cytogam was not a major contributor to growth this quarter, indicating potential challenges in its market performance. The company faces uncertainties related to global trade tariffs, although currently, no direct impact is anticipated. There is a significant increase in the reported tax rate, from 3% to 40%, although it was noted as a non-cash expense. Enrollment for the phase 3 inhaled Alpha 1 program is only at 55%, indicating potential delays in reaching full enrollment. The company is still utilizing net operating losses (NOLs) and expects to start paying taxes by the end of 2025 or early 2026, which could impact future cash flows. Warning! GuruFocus has detected 3 Warning Sign with KMDA. Q: I noticed that Cytogam isn't cited as a growth contributor this quarter. With your expanded investment in clinical studies for Cytogam, should we read into anything about its current status or potential guideline updates? A: (Amir London, CEO) The year-over-year growth was primarily driven by other products. Cytogam's sales were similar to Q1 2024, as we had a strong quarter back then due to fresh inventory. The expanded studies aim to present new clinical data, which started in 2023, to potentially update guidelines and demonstrate Cytogam's advantages in CMV management. Q: How do you view the potential impact of tariffs on your global business, especially considering pharmaceuticals are currently excluded? A: (Jaime Olov, CFO) Based on our evaluation, there should be no direct impact on our product sales. However, we will continue to monitor the situation as it evolves. Currently, we do not foresee any direct impact on our business. Q: Can you provide an update on the enrollment status for the Innovate trial? A: (Amir London, CEO) We have achieved around 55% enrollment and are progressing well. We plan to conduct a futility analysis with a data cutoff in the second half of the year, after which the data will be available for analysis. Q: Regarding the Cytogam post-marketing study, can you discuss the timeline for its completion? A: (Amir London, CEO) The program consists of 10 different studies, each with its own timeline. Some results will be available later this year into 2026, while others will continue through 2027-2028. Overall, it's a four-year program across multiple sites and KOLs. Q: You reported a 40% tax rate this quarter compared to 3% a year ago. What caused this change, and are these real cash taxes? A: (Jaime Olov, CFO) The tax rate change is due to shifts between deferred tax assets and liabilities, with no cash effect. We expect fluctuations in tax expenses through 2025, but it should stabilize by year-end. We anticipate starting to pay taxes at the end of 2025 or early 2026. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
